» Articles » PMID: 17400610

Protection of CD8+ T Cells from Activation-induced Cell Death by IL-18

Overview
Journal J Leukoc Biol
Date 2007 Apr 3
PMID 17400610
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Role of IL-18 on proliferation and survival of CD8+ T cells, activated by immobilized anti-CD3 antibody (anti-CD3), was examined. Proliferation and survival of activated T cells, especially that of CD8+ T cells, were impaired by IL-18 deficiency [IL-18 knockout (KO)]. After 3 days of culture with anti-CD3, the number of living CD8+ T cells from IL-18KO mice was approximately 25% of that from wild-type (WT) mice but was increased to the same level as WT cells by the addition of IL-18. The expression of IL-18 receptors (IL-18Rs), particularly IL-18Rbeta chain, in naïve CD8+ T cells was very low but elevated after stimulation with anti-CD3. Blockade of IL-18R by anti-IL-18R antibody on activated WT CD8+ T cells resulted in reduction of living cells, suggesting that IL-18 promotes survival of proliferating CD8+ T cells. Levels of Bcl-2 in activated IL-18KO CD8+ T cells were lower than those in WT cells but were raised by exogenous IL-18. Blockade of IL-18R on WT CD8+ T cells decreased the expression of surface markers CD122 and CD94, which are related to cell viability, and the expression of these markers was increased by exogenous IL-18 in IL-18KO cells. These results suggest that IL-18 acts directly on activated CD8+ T cells through IL-18Rs and promotes their survival to expand the population.

Citing Articles

Inflammasome and Inflammatory Programmed Cell Death in Chromoblastomycosis.

Pagliari C, Kanashiro-Galo L, Sotto M Mycopathologia. 2022; 188(1-2):63-70.

PMID: 36273348 DOI: 10.1007/s11046-022-00679-w.


DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor-infiltrating T cells through IL-18.

Duan X, Xu X, Zhang Y, Gao Y, Zhou J, Li J Cancer Sci. 2022; 113(11):3672-3685.

PMID: 35969377 PMC: 9633303. DOI: 10.1111/cas.15533.


The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?.

Morris G, Bortolasci C, Puri B, Marx W, ONeil A, Athan E Cytokine. 2021; 144:155593.

PMID: 34074585 PMC: 8149193. DOI: 10.1016/j.cyto.2021.155593.


Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experience.

Oft M Semin Immunol. 2019; 44:101325.

PMID: 31706853 PMC: 7129358. DOI: 10.1016/j.smim.2019.101325.


Myeloid differentiation factor 88 signaling in donor T cells accelerates graft--host disease.

Matsuoka S, Hashimoto D, Kadowaki M, Ohigashi H, Hayase E, Yokoyama E Haematologica. 2019; 105(1):226-234.

PMID: 31048358 PMC: 6939524. DOI: 10.3324/haematol.2018.203380.